About Us

Alphageneron Pharmaceuticals is a clinical-stage biopharmaceutical company commercializing cell and gene therapies for hematologic and solid cancer.

Our main immune system are lymphocytes, a type of white blood cell, that include natural killer (NK) cells that provide an innate first line of defense, T-cells that provide adaptive immunity, and B-cells that produce antibodies. Alphageneron is developing revolutionary therapies utilize autologous and allogeneic NK cells and T-cells, in combination with antibodies.

Our seasoned team of biopharmaceutical executives, scientists and clinicians in the United States and Europe, brings decades of experience, integral to the success of our Company.